DISCOVERY CAPITAL MANAGEMENT, LLC / CT - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
DISCOVERY CAPITAL MANAGEMENT, LLC / CT ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$2,037,869
-74.5%
15,461,829
-1.2%
0.36%
-56.9%
Q2 2023$7,977,942
-19.0%
15,643,0230.0%0.84%
-25.1%
Q1 2023$9,855,104
-6.2%
15,643,023
-3.4%
1.12%
-26.8%
Q4 2022$10,506,331
-58.3%
16,185,998
+10.5%
1.53%
-59.3%
Q3 2022$25,186,000
+43.8%
14,642,959
+3.7%
3.76%
+66.7%
Q2 2022$17,515,000
+91.6%
14,125,079
+0.8%
2.26%
+187.9%
Q1 2022$9,142,000
-37.2%
14,013,093
+5.0%
0.78%
-28.3%
Q4 2021$14,548,000
-36.3%
13,346,493
+6.4%
1.09%
-36.0%
Q3 2021$22,835,000
-30.7%
12,546,493
+0.5%
1.71%
-19.8%
Q2 2021$32,966,000
-24.0%
12,487,227
+3.6%
2.13%
-63.3%
Q1 2021$43,380,000
+43.5%
12,050,007
+0.5%
5.81%
+56.0%
Q4 2020$30,220,000
+15.2%
11,992,023
+15.2%
3.73%
-7.3%
Q3 2020$26,225,000
-17.1%
10,406,850
+7.9%
4.02%
-30.0%
Q2 2020$31,628,000
+35.3%
9,642,760
+1.0%
5.74%
-10.7%
Q1 2020$23,380,000
+5.5%
9,542,760
+103.2%
6.43%
-8.7%
Q4 2019$22,169,000
+23.6%
4,696,746
+12.1%
7.04%
+134.5%
Q3 2019$17,938,000
+11.8%
4,191,127
+52.3%
3.00%
+96.1%
Q2 2019$16,041,000
+137.2%
2,751,388
+56.6%
1.53%
+117.5%
Q1 2019$6,764,0001,756,8130.70%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
EXANE DERIVATIVES 40,660$26,525,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders